[(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models.

Mol Imaging Biol

Department of Radiation Oncology (MaastRO Lab), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, UNS 50/23, PO Box 616, 6200 MD, Maastricht, The Netherlands.

Published: October 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: [(18)F]VM4-037 was recently developed as a positron emission tomography (PET) tracer for the detection of carbonic anhydrase IX (CAIX), a tumor-specific protein upregulated under hypoxic conditions. In this study, the accumulation of [(18)F]VM4-037 was determined in two CAIX-expressing preclinical human tumor models.

Procedures: U373 and HT29 tumor-bearing animals were injected with [(18)F]VM4-037 and underwent microPET imaging up to 4 h post-injection (p.i.). Biodistribution throughout the different organs was assessed at 2 and 4 h p.i. using gamma counting.

Results: MicroPET imaging showed high [(18)F]VM4-037 uptake in the abdominal region, and biodistribution revealed high radioactivity in the kidney, ileum, colon, liver, stomach, and bladder. Although high CAIX expression was confirmed in both tumor models, tumor uptake assessed with microPET and biodistribution experiments was comparable to background tissues.

Conclusions: In this study, [(18)F]VM4-037 does not specifically accumulate in CAIX-expressing tumors, indicating that the tracer is not suitable for the detection of CAIX.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768225PMC
http://dx.doi.org/10.1007/s11307-015-0831-yDOI Listing

Publication Analysis

Top Keywords

micropet imaging
12
tumor models
8
[18f]vm4-037
6
[18f]vm4-037 micropet
4
biodistribution
4
imaging biodistribution
4
biodistribution vivo
4
vivo caix-expressing
4
tumor
4
caix-expressing tumor
4

Similar Publications

Purpose: While PSMA-targeted radioligand therapy (RLT) has shown remarkable efficacy for treating end-stage prostate cancer, the α-emitting RLT often results in severe salivary gland toxicity, limiting its use. Various strategies to mitigate this side effect have been attempted with limited success. Accordingly, this study introduced a new PSMA-targeting ligand with more favorable binding characteristics than the existing ligands.

View Article and Find Full Text PDF

Rationale And Objectives: Prolonged oxidative stress, driven by aggregation of misfolded proteins such as amyloid beta (Aβ), alpha-synuclein (aSyn), and tau, plays a key role in neurodegenerative disease (ND) progression. Yet, the lack of noninvasive tools to monitor oxidative stress in vivo limits clinical tracking of disease. To address this, we evaluated [18 F]ROStrace, a novel superoxide (O₂·⁻)-sensitive PET tracer, in three proteinopathy-associated ND mouse models.

View Article and Find Full Text PDF

Design, Synthesis, and Preclinical Evaluation of Zr/Lu-FAPI-Tz: A Potential Theranostic Pair Targeting Fibroblast Activation Protein.

Bioconjug Chem

August 2025

Key Laboratory of Radiation Physics and Technology of the Ministry of Education, Institute of Nuclear Science and Technology, Sichuan University, Chengdu 610064, P. R. China.

Fibroblast activation protein (FAP)-targeted radioligands have recently emerged as attractive tumor imaging agents. However, the therapeutic applicability of most FAP ligands has been impeded by their short tumor retention. In this study, a tetrazine (Tz)-modified FAPI derivant DOTA-FAPI-Tz was synthesized and radiolabeled with Lu and Zr to produce Zr-FAPI-Tz and Lu-FAPI-Tz with high radiochemical purity.

View Article and Find Full Text PDF

Rationale: [C]DASB is widely used for PET imaging of brain serotonin transporters (SERT) and the tropane ligand [F]FE-PE2I is used for PET imaging of dopamine transporters (DAT). However, their in vivo selectivity has not been confirmed using knockout (KO) models. This study aimed to provide direct in vivo evidence for the selectivity of these tracers using SERT and DAT KO rats.

View Article and Find Full Text PDF

Myeloperoxidase (MPO), a well-established biomarker of neutrophil activation, plays a crucial role in early acute inflammation. In the study, we developed an MPO-specific PET ligand, Ga-NOTA-3G-bis-5HT, for noninvasive imaging of early acute inflammation. Ga-NOTA-3G-bis-5HT was achieved with a radiochemical yield of >70%, radiochemical purity of >95%, and molar activity of 6.

View Article and Find Full Text PDF